Related Experiment Video
Updated: Aug 14, 2025
08:05
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
14.3K
Differences in Clinical and Imaging Features between Asymptomatic and Symptomatic COVID-19 Patients.
Xi Ma1, Zhi-Yan Lu2, Yan-Juan Qu2
1CT/MRI Room, Affiliated Hospital of Hebei University, Baoding, Hebei Province 071000, China.
International Journal of Clinical Practice
|January 9, 2023
Summary
Asymptomatic severe acute respiratory syndrome coronavirus 2 carriers show distinct early lung imaging patterns and faster recovery than symptomatic patients. Early intervention is crucial for preventing transmission and improving outcomes.
Area of Science:
- Radiology
- Infectious Diseases
- Pulmonology
Background:
- Asymptomatic carriers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pose a significant public health challenge.
- Understanding their clinical and imaging characteristics is vital for disease control.
Purpose of the Study:
- To compare the clinical and chest computed tomography (CT) imaging features of asymptomatic SARS-CoV-2 carriers with those of symptomatic COVID-19 patients.
- To analyze the progression and resolution patterns of pulmonary lesions in both groups.
Main Methods:
- Retrospective analysis of clinical and chest CT data from 47 asymptomatic SARS-CoV-2 carriers and 36 symptomatic COVID-19 patients.
- Serial CT scans (4-6 per patient) were performed over 2-5 days to track lesion evolution.
Main Results:
- Asymptomatic carriers and symptomatic patients shared similar demographic and laboratory findings (e.g., decreased lymphocytes, abnormal liver/renal function, elevated D-dimer/C-reactive protein).
- Early-stage pulmonary lesions in asymptomatic carriers were less extensive (1-2 lobes, peripheral) compared to symptomatic patients (>3 lobes, central/peripheral).
- Asymptomatic carriers demonstrated faster lesion absorption, peripheral localization during improvement, and a shorter disease onset to peak progression duration.
Conclusions:
- Asymptomatic SARS-CoV-2 carriers can develop symptoms and are potential transmission sources, despite exhibiting less severe pulmonary damage and better prognosis.
- Early identification, isolation, and intervention are essential to mitigate transmission and improve clinical outcomes for asymptomatic carriers.
Related Concept Videos
01:27Myocarditis II: Clinical Features and Diagnostic Tests
18
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
18
01:25Endocarditis II: Clinical Features of Infective Endocarditis
21
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
21
01:19Pericarditis II: Clinical Features and Diagnostic Tests
17
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
17
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
01:20COPD: Pathogenesis and Clinical Features
424
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
424
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
41
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
41